Fig. 3
From: Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer
Survival rate of each TNBC cohort. High expression of TROP2 was related to poor prognosis. In the three cohorts, there were no significant differences between TROP2 expression and survival rate. a Survival rate of Cohort 1 (p = .676, log-rank) b Survival rate of Cohort 2 (p = .627, log-rank) c Survival rate of Cohort 3 (p = .059, log-rank)